BRIEF-Simcere Pharmaceutical Says Option To License Agreement Of Sim0500 With Abbvie

Like
Comment
Favorite

BRIEF-Simcere Pharmaceutical Says Option To License Agreement Of Sim0500 With Abbvie

Reuters01-13

Jan 13 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK:

OPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR RIGHTS OUTSIDE GREATER CHINA
OPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR RIGHTS OUTSIDE GREATER CHINA
UNDER DEAL CO TO RECEIVE UPFRONT PAYMENT FROM ABBVIE, ELIGIBLE TO RECEIVE OPTION FEES & MILESTONE PAYMENTS OF UP TO $1.055 BILLION

Further company coverage: 2096.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

抱歉，当前请求异常(-1)

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2503586364?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-01-13 23:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503586364","market":"us","top_or_hot":-1,"title":"BRIEF-Simcere Pharmaceutical Says Option To License Agreement Of Sim0500 With Abbvie","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Simcere Pharmaceutical Says Option To License Agreement Of Sim0500 With Abbvie </title></head><body><p><span>Jan 13 (Reuters)</span><span> - </span>Simcere Pharmaceutical Group Ltd <span>2096.HK</span>:</p><ul><li><p>OPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR RIGHTS OUTSIDE GREATER CHINA</p></li><li><p>OPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR RIGHTS OUTSIDE GREATER CHINA</p></li><li><p>UNDER DEAL CO TO RECEIVE UPFRONT PAYMENT FROM ABBVIE, ELIGIBLE TO RECEIVE OPTION FEES &amp; MILESTONE PAYMENTS OF UP TO $1.055 BILLION</p></li></ul><p>Further company coverage: <span>2096.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Simcere Pharmaceutical Says Option To License Agreement Of Sim0500 With Abbvie</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Simcere Pharmaceutical Says Option To License Agreement Of Sim0500 With Abbvie\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-01-13 23:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Simcere Pharmaceutical Says Option To License Agreement Of Sim0500 With Abbvie </title></head><body><p><span>Jan 13 (Reuters)</span><span> - </span>Simcere Pharmaceutical Group Ltd <span>2096.HK</span>:</p><ul><li><p>OPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR RIGHTS OUTSIDE GREATER CHINA</p></li><li><p>OPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR RIGHTS OUTSIDE GREATER CHINA</p></li><li><p>UNDER DEAL CO TO RECEIVE UPFRONT PAYMENT FROM ABBVIE, ELIGIBLE TO RECEIVE OPTION FEES &amp; MILESTONE PAYMENTS OF UP TO $1.055 BILLION</p></li></ul><p>Further company coverage: <span>2096.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BVYPNV92.GBP","symbol_name":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O913Z:1","article_id":"2503586364","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503586364","pubTimestamp":1736780844,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Simcere Pharmaceutical Says Option To License Agreement Of Sim0500 With Abbvie Jan 13  - Simcere Pharmaceutical Group Ltd 2096.HK:OPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR RIGHTS OUTSIDE GREATER CHINAOPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR RIGHTS OUTSIDE GREATER CHINAUNDER DEAL CO TO RECEIVE UPFRONT PAYMENT FROM ABBVIE, ELIGIBLE TO RECEIVE OPTION FEES & MILESTONE PAYMENTS OF UP TO $1.055 BILLIONFurther company coverage: 2096.HK ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","IE00BGHQF631.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","LU1718418525.SGD":"JPMorgan Investment Funds - Global Select Equity A (acc) SGD","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","IE00B42XCP33.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) INC","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","BK4550":"红杉资本持仓","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU1496350171.SGD":"FRANKLIN DIVERSIFIED BALANCED \"A\" (SGDHDG) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","LU0553294199.USD":"BGF GLOBAL EQUITY INCOME \"A5G\" (USD) INC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4581":"高盛持仓","LU1732800096.USD":"摩根大通环球收益基金A (irc)","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","ABBV":"艾伯维公司","LU1037948897.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (HKD) INC","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","LU1934455194.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (USD) ACC","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","LU1934455863.HKD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (HKD) ACC","02096":"先声药业","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","BK4585":"ETF&股票定投概念","LU0738911758.USD":"Blackrock Global Equity Income A6 USD","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC"},"translate_title":"简介-先声药业表示可选择与艾伯维签订Sim0500许可协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02096":0.9,"ABBV":0.9},"content_text":"BRIEF-Simcere Pharmaceutical Says Option To License Agreement Of Sim0500 With Abbvie Jan 13 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK:OPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR RIGHTS OUTSIDE GREATER CHINAOPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR RIGHTS OUTSIDE GREATER CHINAUNDER DEAL CO TO RECEIVE UPFRONT PAYMENT FROM ABBVIE, ELIGIBLE TO RECEIVE OPTION FEES & MILESTONE PAYMENTS OF UP TO $1.055 BILLIONFurther company coverage: 2096.HK ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}